JIm Cramer: Investors Should Be Cautious With Teva Pharmaceutical
Jim Cramer discusses why investors should be cautious after Teva Pharmaceutical's CEO left the company.
Teva Pharmaceutical's (TEVA) - Get Report CEO is out, and TheStreet's Jim Cramer said there are reasons that investors in the company should be cautious.
